<![CDATA[Sequencing CAR T-Cell Therapy and Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma]]>

Summary

Dr. Binod Dhakal discusses clinical sequencing strategies for BCMA-directed therapies, including CAR T-cell therapy and bispecific antibodies, in relapsed/refractory multiple myeloma. This is an educational discussion on treatment landscape navigation rather than a clinical development announcement.